Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:


Last Updated: January 27, 2023

Perrigo R And D Company Profile

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

What is the competitive landscape for PERRIGO R AND D, and what generic and branded alternatives to PERRIGO R AND D drugs are available?

PERRIGO R AND D has forty-four approved drugs.

Summary for Perrigo R And D
US Patents:0

Drugs and US Patents for Perrigo R And D

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Perrigo R And D GUAIFENESIN guaifenesin TABLET, EXTENDED RELEASE;ORAL 078912-001 Nov 23, 2011 OTC No No See Plans and Pricing See Plans and Pricing
Perrigo R And D NICOTINE POLACRILEX nicotine polacrilex TROCHE/LOZENGE;ORAL 090821-002 Jul 10, 2009 OTC No No See Plans and Pricing See Plans and Pricing
Perrigo R And D RANITIDINE HYDROCHLORIDE ranitidine hydrochloride TABLET;ORAL 091429-002 May 11, 2011 DISCN No No See Plans and Pricing See Plans and Pricing
Perrigo R And D CETIRIZINE HYDROCHLORIDE ALLERGY cetirizine hydrochloride TABLET;ORAL 078336-001 Dec 27, 2007 OTC No No See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.